INSIGHTS ON CLINICAL TRIAL DESIGN

• The Evolving Landscape Of Radiopharmaceuticals In Oncology Research

  From selecting appropriate targeting molecules to optimizing dosing strategies and managing off-target effects, radiopharmaceutical development demands a tailored and strategic clinical approach.

• A Framework For Selecting Reliable Clinical Endpoints From Real-World DHT Data

  Dr. Andy Liu presents a case study determining which digital measure of physical activity would be a well-defined and reliable clinical endpoint in a trial including patients with diabetes.

• Developing And Validating Clinical Receptor Occupancy Pharmacodynamic Biomarker Assays

  Receptor occupancy (RO) assays assess drug-target engagement and support PK/PD modeling. Accurate RO requires customized assays using stabilized blood to monitor CD6 modulation in autoimmune therapy.

• Busting Through Patient Recruitment Barriers

  Building patient trust fuels engagement, data and technology enable targeted recruitment, and real-time patient identification with consistent support drives scalable enrollment success.

• Why Operational Design Determines Recruitment And Retention

  4/22/2026

  Patient recruitment challenges often receive the most attention in clinical trials, yet many enrollment and retention issues stem from operational friction embedded in study design.

• Sol-Gel Builds Awareness Of Rare Skin Condition, Generates Leads

  4/1/2026

  Explore a 60-day HCP Awareness email campaign that surpassed industry benchmarks and generated a substantial number of leads.

• Improving Patient Access Through Home-Based Trials, Site Networks

  10/23/2024

  By implementing home trial support, sponsors can improve patient access, enhance diversity, and ultimately accelerate the development of new therapies.

• Scout's Science-Based Targets Commitment: What Comes Next

  1/14/2026

  Explore the latest Science Based Targets initiative commitment, clarifying what has been approved, what remains in progress, and the steps required before emissions reduction targets can be validated.

• Faster Starts, Stronger Finish: Operational Excellence In NSCLC

  5/22/2026

  In NSCLC trials, data‑driven site selection, streamlined protocols, efficient screening strategies, and proactive engagement can accelerate enrollment and improve trial efficiency across regions.